BSEBoard Meeting1d ago · 16 Oct 2026, 04:36 pm

Amwill Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2026 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the half year ended September 30, 2026 (H1) of Financial Year 2026-27 and consider declaration of an interim dividend to the equity shareholders.

Amwill Health Care Ltd · 544353

✦ AI SummaryResults

Amwill Health Care Ltd has scheduled a board meeting on October 23, 2026, to consider and approve unaudited financial results for the half year ended September 30, 2026, and to consider declaration of an interim dividend to equity shareholders.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Amwill Health Care Ltd - 544353 - Board Meeting Intimation for Approval And Take On Record Unaudited Financial Results Of The Company For The Half Year Ended September 30, 2026 (H1) Of Financial Year 2026-27 And Consider Declaration Of An Interim Dividend To The Equity Shareholders.

Attachments (1)

📄

0beff384-1b09-4b9f-8738-b0983fb85bca.pdf

pdf

Download →
View document text
Date: 16.10.2026 The Bombay Stock Exchange (BSE Limited) Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai- 400001 Company Scrip Code.: 544353 RE: Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Subject: Intimation of Meeting of the Board of Directors of the Company to be held on Friday, October 23rd, 2026 to consider Un-audited financial results & declaration of interim dividend. Dear Sir/Madam, Pursuant to Regulation 29 (1) and other applicable provisions of the SEBI Listing Regulations, we would like to inform that the Meeting of the Board of Directors of the Company will be held on Friday, October 23rd, 2026, inter-alia to consider the following: 1. Approve and take on record Unaudited Financial Results of the Company for the half year ended September 30, 2026 (H1) of Financial Year 2026-27. 2. Consider declaration of an interim dividend to the equity shareholders. Further, in continuation to our earlier intimation dated September 28, 2026, in compliance of the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company’s “Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Person" (“Insider Trading Policy”), the Trading Window for dealing in the securities of the Company for all the Designated Persons, their relatives and Insiders, as per the Insider Trading Policy had already been closed with effect from October 01, 2026, and same shall be opened after 48 hours of announcement of Unaudited Financial Results. This information will also be made available on the Company’s Website at: www.amwillhealthcare.com. You are requested to take the above information on records. Thanking You. FOR AMWILL HEALTH CARE LIMITED ANSHU ANSHUMAN Company Secretary and Compliance Officer ACS:65515 Place: Bangalore